Gene Solutions and AMPATH Launch Next-Gen Lab in Hyderabad

Gene Solutions, a prominent genetic testing innovator in Asia, has joined forces with AMPATH, a leading provider of diagnostic services in India, to establish a state-of-the-art genomics laboratory in Hyderabad. Announced on October 1, 2025, this collaboration aims to enhance access to precision medicine across the country by leveraging advanced technologies in next-generation sequencing (NGS).

This partnership combines AMPATH’s extensive diagnostic infrastructure, which includes over 20 satellite laboratories and more than 2,000 collection points, with Gene Solutions’ expertise in genomic technologies. The new facility in Hyderabad is set to transform the landscape of medical testing, making high-value genomic solutions readily accessible to patients and healthcare providers.

Enhancing Diagnostic Capabilities for Improved Patient Care

The launch of the NGS laboratory is geared towards improving patient care through timely and informative testing in critical areas such as reproductive health, cancer screening, and personalized medicine. By integrating advanced genomic technologies into routine diagnostics, the collaboration seeks to support healthcare professionals in making more informed clinical decisions.

Dr. Nguyen Hoai Nghia, Co-founder and CEO of Gene Solutions, emphasized the importance of this partnership, stating, “This collaboration reflects a shared vision—making high-quality, science-driven genetic testing more widely available. We believe that technology should be inclusive. Working with AMPATH allows us to deliver advanced solutions through a familiar and trusted healthcare network.”

Dr. Maneesh Bagai, COO of AMPATH, expressed enthusiasm about the alliance, noting, “We are thrilled to expand into next-generation sequencing through this strategic alliance. Together, we are redefining what’s possible in diagnostics—whether it’s in maternal health, early cancer detection, or personalized oncology with a patient-centric approach.”

About the Partners and Their Commitment to Precision Medicine

AMPATH is recognized as a leader in pathology services in India, adhering to international standards for clinical diagnostics. With its headquarters in Hyderabad, AMPATH operates a Central Reference Laboratory and a growing network that is supported by the National Accreditation Board for Testing & Calibration Laboratories (NABL) accreditation. The organization is part of CTSI South Asia, which also includes the American Oncology Institute (AOI) and a network of specialty hospitals, further reinforcing its commitment to patient-centric healthcare.

Gene Solutions, on the other hand, is a multinational biotechnology firm that specializes in genetic testing and research innovation throughout the Asia-Pacific region. Utilizing NGS and artificial intelligence, the company provides a wide range of services, including non-invasive prenatal testing (NIPT), cancer screening via circulating tumor DNA (ctDNA), genomic profiling, and treatment monitoring. With over two million genetic tests delivered, Gene Solutions is recognized for its contributions to advancing precision medicine through clinical studies and regional collaborations.

The establishment of this advanced genomics laboratory is set to play a pivotal role in expanding access to precision medicine in India, ultimately benefiting patients and healthcare providers alike. For further details, visit Gene Solutions’ official website at [genesolutions.com](https://genesolutions.com/).